Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes
Clinical trial NCT01017731 · COMPLETED
Trial details
- NCT number
- NCT01017731
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-04-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.